Annual FCF
-$37.60 M
-$11.03 M-41.48%
December 31, 2023
Summary
- As of February 8, 2025, TARA annual free cash flow is -$37.60 million, with the most recent change of -$11.03 million (-41.48%) on December 31, 2023.
- During the last 3 years, TARA annual FCF has fallen by -$13.31 million (-54.80%).
- TARA annual FCF is now -585.42% below its all-time high of -$5.49 million, reached on December 31, 2019.
Performance
TARA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$8.44 M
-$700.00 K-9.04%
September 30, 2024
Summary
- As of February 8, 2025, TARA quarterly free cash flow is -$8.44 million, with the most recent change of -$700.00 thousand (-9.04%) on September 30, 2024.
- Over the past year, TARA quarterly FCF has dropped by -$1.84 million (-27.95%).
- TARA quarterly FCF is now -116.80% below its all-time high of -$3.89 million, reached on September 30, 2020.
Performance
TARA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$35.26 M
-$1.84 M-5.52%
September 30, 2024
Summary
- As of February 8, 2025, TARA TTM free cash flow is -$35.26 million, with the most recent change of -$1.84 million (-5.52%) on September 30, 2024.
- Over the past year, TARA TTM FCF has dropped by -$1.33 million (-3.92%).
- TARA TTM FCF is now -376.98% below its all-time high of -$7.39 million, reached on March 31, 2020.
Performance
TARA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
TARA Free Cash Flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -41.5% | -27.9% | -3.9% |
3 y3 years | -54.8% | -27.9% | -3.9% |
5 y5 years | -61.0% | -27.9% | -3.9% |
TARA Free Cash Flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -41.5% | at low | -67.8% | +34.5% | -32.7% | +6.2% |
5 y | 5-year | -585.4% | at low | -116.8% | +34.5% | -377.0% | +6.2% |
alltime | all time | -585.4% | at low | -116.8% | +34.5% | -377.0% | +6.2% |
Protara Therapeutics Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$8.44 M(+9.0%) | -$35.26 M(+5.5%) |
Jun 2024 | - | -$7.74 M(-25.4%) | -$33.42 M(-4.8%) |
Mar 2024 | - | -$10.38 M(+19.3%) | -$35.09 M(-6.7%) |
Dec 2023 | -$37.60 M(+41.5%) | -$8.70 M(+31.9%) | -$37.60 M(+10.8%) |
Sep 2023 | - | -$6.60 M(-29.9%) | -$33.93 M(+3.6%) |
Jun 2023 | - | -$9.41 M(-27.0%) | -$32.77 M(+15.0%) |
Mar 2023 | - | -$12.89 M(+156.2%) | -$28.50 M(+7.2%) |
Dec 2022 | -$26.58 M | -$5.03 M(-7.3%) | -$26.58 M(-6.7%) |
Sep 2022 | - | -$5.43 M(+5.6%) | -$28.50 M(-2.4%) |
Jun 2022 | - | -$5.14 M(-53.1%) | -$29.20 M(-13.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$10.97 M(+57.8%) | -$33.86 M(-3.5%) |
Dec 2021 | -$35.10 M(+44.5%) | -$6.95 M(+13.3%) | -$35.10 M(-0.9%) |
Sep 2021 | - | -$6.14 M(-37.4%) | -$35.42 M(+6.8%) |
Jun 2021 | - | -$9.80 M(-19.7%) | -$33.18 M(+14.0%) |
Mar 2021 | - | -$12.21 M(+67.8%) | -$29.11 M(+19.8%) |
Dec 2020 | -$24.29 M(+342.8%) | -$7.28 M(+86.9%) | -$24.29 M(+42.8%) |
Sep 2020 | - | -$3.89 M(-32.0%) | -$17.01 M(+29.7%) |
Jun 2020 | - | -$5.73 M(-22.5%) | -$13.12 M(+77.5%) |
Mar 2020 | - | -$7.39 M | -$7.39 M |
Dec 2019 | -$5.49 M(-76.5%) | - | - |
Dec 2018 | -$23.35 M | - | - |
FAQ
- What is Protara Therapeutics annual free cash flow?
- What is the all time high annual FCF for Protara Therapeutics?
- What is Protara Therapeutics annual FCF year-on-year change?
- What is Protara Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Protara Therapeutics?
- What is Protara Therapeutics quarterly FCF year-on-year change?
- What is Protara Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Protara Therapeutics?
- What is Protara Therapeutics TTM FCF year-on-year change?
What is Protara Therapeutics annual free cash flow?
The current annual FCF of TARA is -$37.60 M
What is the all time high annual FCF for Protara Therapeutics?
Protara Therapeutics all-time high annual free cash flow is -$5.49 M
What is Protara Therapeutics annual FCF year-on-year change?
Over the past year, TARA annual free cash flow has changed by -$11.03 M (-41.48%)
What is Protara Therapeutics quarterly free cash flow?
The current quarterly FCF of TARA is -$8.44 M
What is the all time high quarterly FCF for Protara Therapeutics?
Protara Therapeutics all-time high quarterly free cash flow is -$3.89 M
What is Protara Therapeutics quarterly FCF year-on-year change?
Over the past year, TARA quarterly free cash flow has changed by -$1.84 M (-27.95%)
What is Protara Therapeutics TTM free cash flow?
The current TTM FCF of TARA is -$35.26 M
What is the all time high TTM FCF for Protara Therapeutics?
Protara Therapeutics all-time high TTM free cash flow is -$7.39 M
What is Protara Therapeutics TTM FCF year-on-year change?
Over the past year, TARA TTM free cash flow has changed by -$1.33 M (-3.92%)